| Literature DB >> 34427794 |
Guido Filler1,2,3,4,5, Rishika Geda6,7, Fabio Salerno8,9, Yun Cong Zhang10, Maria E Díaz-González de Ferris11, Christopher William McIntyre12,13,6,8,9.
Abstract
BACKGROUND: Polyuria is a common problem in patients with tubular diseases, especially for those with CKD and high-output Fanconi syndrome. There are currently no guidelines on how to treat debilitating polyuria, in children or adults, and vasopressin is usually not effective. CASE-DIAGNOSIS/TREATMENT: A 13-year-old female with idiopathic Fanconi syndrome and an eGFR of 69 mL/min/1.73 m2 was severely affected by polyuria of 5 L per day (voiding at least 11 times during the day and up to 8 times at night), impacting her mood (measured by the RCADS-child) and academic performance at school. In the absence of guidelines and with literature discouraging the use of indomethacin in this condition, we attempted indomethacin treatment at a dose of 2 mg/kg divided in two doses with substantial success. Urine output dropped to 2.5L and this was accompanied by a substantial decrease of her sodium wasting from 24.6 to 7.7 mmol/kg/day. Over the course of 18 months, the patient's eGFR dropped temporarily to 60 mL/min/1.73 m2 and was 68 mL/min/1.73 m2 at last follow-up. However, a sodium-23 (23Na) MRI of her thigh revealed ongoing moderate sodium decrease in her skin and substantial Na+ decrease in her muscle when compared to age-matched peers with normal kidney function.Entities:
Keywords: Academic performance; Fanconi syndrome; Indomethacin; Mood and quality of life; Polyuria; Sodium-23 (23Na) MRI; Tubular defect; Reduction of free water clearance
Mesh:
Substances:
Year: 2021 PMID: 34427794 DOI: 10.1007/s00467-021-05213-6
Source DB: PubMed Journal: Pediatr Nephrol ISSN: 0931-041X Impact factor: 3.714